Join us for the free lecture “Integrative Oncology: An Evolving Discipline” on November 13, 2015, from 8:00 a.m. to 9:00 a.m. at the Davis Auditorium at the Larner College of Medicine at UVM. This lecture is part of The Laura Mann Integrative Healthcare Lecture Series and Medicine Grand Rounds. Presented by David Rosenthal, MD an Integrative oncology consultant, Leonard P. Zakim Center for Integrative Therapies at the Dana-Farber Cancer Institute.
When David Rosenthal, MD, started treating patients with leukemia and lymphoma, he wondered: How can I improve the quality of life of my patients? He noticed that the therapy delivered cause a range of side effects, from nausea to vomiting to neuropathies. After seeing the positive effects of acupuncture, he realized that the emerging field of integrative medicine could aid in symptom relief and act as a complementary therapy.
Years later, Dr. Rosenthal is an integrative oncology consultant at the Leonard P. Zakim Center for Integrative Therapies at the Dana-Farber Cancer Institute. On November 13, 2015, he will deliver a lecture on the evolving discipline of integrative oncology at the UVM Medical Center. The event is free and open to the public.
What is Integrative Oncology?
Integrative oncology is a relatively new field that combines the best of Eastern and Western medicine. Many of our Western therapies come with costs and side effects. Integrative medicine seeks to cure and abate these symptoms using a range of techniques, including acupuncture, meditation, music and expressive arts therapy, yoga, Tai Chi, Qigong, and more.
The Zakim Center seeks to build knowledge about the effectiveness of these therapies through peer-reviewed, evidence-based research. Research conducted by Dana-Farber investigators and others has shown that, when used in conjunction with traditional cancer care, complementary therapies can help ease cancer-related symptoms and improve your quality of life. Medical experts worldwide now view integrative therapies as an effective complement to surgery, chemotherapy, and radiation.
What Can I Expect at the Talk?
I will take us on a journey across the history of integrative oncology, from its American introduction by the American Cancer Society in the 1970s to today, where we have the NIH National Center for Complementary and Integrative Health. I will also discuss effective integrative therapies, including massage, acupuncture, supplements and herbs, physical activity and nutrition, and more for cancer patients.
As a Patient, What Should I do to Explore Integrative Oncology?
Attend the talk! Dr. Rosenthal suggests that you talk to your primary oncologist to find out what vetted and reputable options are available in your neck of the woods. The key is to find out who is doing integrative medicine safely. Another great resource is the NIH Center for Complementary and Integrative Health. Ideally, your integrative oncology path should be navigated among you, your doctor and your integrative therapist as a team.
What Integrative Oncology Therapies Does the UVM Medical Center Offer?
The UVM Medical Center offers many options to cancer patients, including:
- Art and Healing
- Healing Touch
- Integrative Medicine Consultations
- Lymphedema Therapy
- Pediatric Oncology: Music, Reiki, and Yoga
- Psychological Counseling
- Steps to Wellness Oncology Rehabilitation
- Support Groups
- Touch, Caring and Cancer
For more information on Integrative Healthcare at UVM and UVM Medical Center please visit www.uvm.edu/pih.
Dr. Rosenthal serves as an integrative oncology consultant at the Leonard P. Zakim Center for Integrative Therapies at the Dana-Farber Cancer Institute, and as a senior physician at Brigham & Women’s Hospital, Beth Israel Deaconess Hospital and Dana-Farber Cancer Institute.
He is the Henry K. Oliver Professor of Hygiene (Emeritus) at Harvard University and Professor of Medicine at Harvard Medical School. He has served as medical director for the Leonard P. Zakim Center for Integrative Therapies; President of the Society for Integrative Oncology; and Director and Chief Executive Officer of Harvard University Health Service.